Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Goldman Sachs

US stocks: Musk's SpaceX prices record $75 billion IPO at $135 a share

SpaceX has priced its record-breaking U.S. IPO at $135 per share, raising $75 billion and valuing the company at $1.77 trillion. This makes it one of the world's most valuable companies, surpassing established giants. The offering, which saw significant retail allocation, culminates Elon Musk's ambitious project despite questions about its…

The Economic Times

Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?

Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth rate of around 18% between FY26 and FY31. Growth is expected to be led by Mamaearth, with revenue projected to exceed ₹2,000 crore, while The Derma Co is…

The Economic Times

Grain Market Update: Are Corn, Wheat, and Soybeans Finally Carving Out a Summer Bottom?

Barchart Senior Market Analyst Darin Newsom analyzes whether the morning's short-covering bounce in grains is a temporary reprieve or a permanent bottom, while breaking down the technical realities of the Goldman roll, a hot 4.2% CPI print, and the critical cash-market triggers dictating the cattle pits.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Billionaire Sam Altman Says OpenAI Was ‘Pretty Wrong’ About AI Jobs, But Goldman Sachs Warns AI is Still Wiping Out 11,000 Jobs Per Month

The AI jobs story has become a split screen: one of the most powerful artificial intelligence (AI) executives is walking back the worst panic, while data tracked by Goldman Sachs (GS ) still points to pressure on younger white-collar workers. The lack of a clean yes-or-no answer is exactly why...

Barchart

Goldman Sachs buys CMR Green Technologies shares on listing day after strong debut

Goldman Sachs India Equity Portfolio bought shares worth Rs 49.82 crore in CMR Green Technologies on its listing day, which saw a 43% premium. Despite investor optimism, analysts advise caution and partial profit booking amid high valuations.

The Economic Times

‘The circulatory system is not working.’ Goldman on what’s really wrong with private markets

Goldman Sachs’ top private markets executives say the industry has reached a structural inflection point—not a crisis. Not everyone agrees.

Fortune

A $7 billion horse race: Goldman Sachs and Morgan Stanley battle to lead OpenAI and Anthropic IPOs

Only one bank can occupy the coveted lead underwriter position for this year's hottest AI IPOs.

Fortune

Read news from The Economist, FT, and more,
with one subscription

SpaceX aims to launch orbital AI computing tests by end of next year

During two investor presentations ahead of the IPO, both featuring President Gwynne Shotwell and Chief Financial Officer Bret Johnsen, SpaceX executives outlined a roadmap to begin demonstrating orbital-compute capabilities in 2027, according to the two people familiar with the discussions. Both sources were at a Goldman Sachs meeting and one…

The Economic Times

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase

Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics portfolio, a newly expanded biosimilars platform and specialty product launches. Speaking at a Gol

MarketBeat

Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts

Alnylam Pharmaceuticals (NASDAQ:ALNY) executives outlined the company’s 2030 financial targets, TTR franchise strategy and near-term pipeline priorities during a Goldman Sachs event hosted by analyst Salveen Richter. Jeff Poulton, Alnylam’s chief financial officer, said the company’s “Alnylam 2030”

MarketBeat

Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure

Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for the denosumab franchise and other losses of exclusivity. Speaking at a Goldman Sachs event, Peter

MarketBeat

IndiGo shares gain 2% after analyst meet. Why Goldman, Morgan Stanley, others see up to 38% upside?

IndiGo shares witnessed an uptick on Tuesday after its analyst meet, where management outlined strong long-term growth plans driven by rising air travel demand and international expansion. Brokerages including Goldman Sachs, Morgan Stanley, Motilal Oswal and Elara Capital reiterated bullish views, seeing up to 38% upside despite near-term geopolitical and…

The Economic Times

Gold extends falls on rising Treasury yields

Gold prices dipped for a third consecutive session, influenced by rising Treasury yields and ongoing Middle East conflict concerns. Goldman Sachs anticipates the Fed will hold rates steady through 2026, while Citi lowered its near-term gold price target due to expected higher U.S. interest rates.

The Economic Times

CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans

CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted discussion. Chief Executive Officer John Hanna said CareDx has reshaped its portfolio around areas

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT. Mark Singleton, Bioventus’ senior vice president and chief financi

International Business Times

Goldman Sachs Sees Fed Holding Rates Until 2027 After Strong Jobs Report

Goldman Sachs has pushed its forecast for the Federal Reserve's next interest rate cuts into 2027, a move that shows how a stronger-than-expected U.S. labor market is reshaping Wall Street's view of the economy and monetary policy.

Fortune

Exclusive: Goldman Sachs intern acceptance rate falls below 1% for third straight year

It's harder to get a Goldman Sachs internship than to get accepted into Harvard, MIT or Stanford.

The Economic Times

FIFA 2026: Brokerages bet on sector winners as soccer World Cup set to kick off

The 2026 FIFA World Cup will bring billions to host nations. Analysts expect a surge in spending on hotels, airlines, and retail. Beer sales are also set to rise. Media companies and online betting platforms will see increased revenue. This global event is poised to boost economies significantly.

Get all your
news in one place.

100's of premium titles.
One news app.

Euronews

The €3trn question: Can markets handle SpaceX, OpenAI and Anthropic all at once?

Three of the most valuable companies ever created are going public within months of each other. The combined value of SpaceX, OpenAI and Anthropic could reach $4 trillion (€3.44trn). Wall Street is excited but also nervous.

The Economic Times

100 days of Iran war, Rs 4,50,000 crore wiped out: Is your stock portfolio safe from missiles?

Indian equities have lost Rs 4.5 lakh crore in 100 days as the Iran-led West Asia conflict and a global AI trade unwind trigger sharp FII outflows. Banking, oil and IT stocks led declines, while pharma outperformed. Analysts warn of earnings downgrades, though valuations are turning attractive in select segments.

Fortune

'Yet another way in which 2026 is looking like 1999’: Top analyst fears bubble popping with investors and Wall Street out over their skis

The Nasdaq's sudden lurch lower on Friday looked like a crack in a story that had seemed, until recently, almost bulletproof.

The Economic Times

Lenskart shares in focus after Viridian completes stake transfer from Copthall Mauritius

Hong Kong-based Viridian Asia Opportunities Master Fund acquired an 18.96 lakh share stake in Lenskart Solutions for Rs 96 crore. This follows a recent Rs 2,873 crore block deal where SoftBank affiliate SVF II Lightbulb (Cayman) reduced its holding.

Evening Standard

Inside the gilded world of the banking elite

The SpaceX listing will make millions for Goldman Sachs, but the image-conscious firm kept its celebrations quiet. Has the finance world changed? Don’t bank on it, says Chris Blackhurst

Fortune

This Gen Zer got reprimanded at Goldman for making cake videos as the ‘Investment Baker.’ She quit her job and is building a dessert empire

Allison Sheehan left her full-time job as a Wall Street wealth manager to scale her cake business, with a CPG brand on the horizon: Alleycat Baking Co.

Fortune

Jamie Dimon called Elon Musk the ‘Edison of our time’ as JPMorgan hosted SpaceX’s $75 billion IPO road show—and even invited Musk’s mom

Top bankers are lavishing praise on Musk ahead of his rocket company’s record-setting listing.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.